MELCOR DEVELOPMENTS LTD (MRD.CA) Fundamental Analysis & Valuation

TSX:MRD • CA5854671032

Current stock price

18.3 CAD
+0.1 (+0.55%)
Last:

This MRD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MRD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MRD was profitable.
  • MRD had a positive operating cash flow in the past year.
  • Each year in the past 5 years MRD has been profitable.
  • Each year in the past 5 years MRD had a positive operating cash flow.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • With a Return On Assets value of 2.85%, MRD perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 4.72%, MRD is in line with its industry, outperforming 58.62% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 5.50%, MRD is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MRD is significantly below the industry average of 18.70%.
  • The 3 year average ROIC (3.82%) for MRD is below the current ROIC(5.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROIC 5.5%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

  • The Profit Margin of MRD (14.91%) is better than 65.52% of its industry peers.
  • MRD's Profit Margin has declined in the last couple of years.
  • MRD has a better Operating Margin (38.68%) than 75.86% of its industry peers.
  • In the last couple of years the Operating Margin of MRD has grown nicely.
  • The Gross Margin of MRD (47.83%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of MRD has remained more or less at the same level.
Industry RankSector Rank
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. MRD.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MRD is destroying value.
  • The number of shares outstanding for MRD has been reduced compared to 1 year ago.
  • The number of shares outstanding for MRD has been reduced compared to 5 years ago.
  • The debt/assets ratio for MRD has been reduced compared to a year ago.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.71, we must say that MRD is in the distress zone and has some risk of bankruptcy.
  • MRD has a Altman-Z score of 1.71. This is in the better half of the industry: MRD outperforms 62.07% of its industry peers.
  • MRD has a debt to FCF ratio of 5.63. This is a neutral value as MRD would need 5.63 years to pay back of all of its debts.
  • MRD has a better Debt to FCF ratio (5.63) than 86.21% of its industry peers.
  • MRD has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • MRD has a Debt to Equity ratio of 0.48. This is in the better half of the industry: MRD outperforms 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Altman-Z 1.71
ROIC/WACC0.98
WACC5.6%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • MRD has a Current Ratio of 3.44. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MRD (3.44) is better than 89.66% of its industry peers.
  • A Quick Ratio of 3.44 indicates that MRD has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.44, MRD belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 3.44
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. MRD.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 414.41% over the past year.
  • MRD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.67% yearly.
  • The Revenue has grown by 29.55% in the past year. This is a very strong growth!
  • MRD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.94% yearly.
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2

7

4. MRD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.63, which indicates a very decent valuation of MRD.
  • Compared to the rest of the industry, the Price/Earnings ratio of MRD indicates a somewhat cheap valuation: MRD is cheaper than 79.31% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of MRD to the average of the S&P500 Index (26.17), we can say MRD is valued rather cheaply.
  • MRD is valuated reasonably with a Price/Forward Earnings ratio of 9.10.
  • 96.55% of the companies in the same industry are more expensive than MRD, based on the Price/Forward Earnings ratio.
  • MRD is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.63
Fwd PE 9.1
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MRD is valued cheaper than 93.10% of the companies in the same industry.
  • 96.55% of the companies in the same industry are more expensive than MRD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.22
EV/EBITDA 6.93
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • MRD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. MRD.CA Dividend Analysis

5.1 Amount

  • MRD has a Yearly Dividend Yield of 3.29%.
  • Compared to an average industry Dividend Yield of 2.89, MRD pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, MRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.29%

5.2 History

  • The dividend of MRD decreases each year by -2.57%.
  • MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MRD has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-2.57%
Div Incr Years2
Div Non Decr Years2
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • MRD pays out 23.67% of its income as dividend. This is a sustainable payout ratio.
  • MRD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP23.67%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MRD.CA Fundamentals: All Metrics, Ratios and Statistics

MELCOR DEVELOPMENTS LTD

TSX:MRD (4/2/2026, 7:00:00 PM)

18.3

+0.1 (+0.55%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners8.79%
Inst Owner ChangeN/A
Ins Owners14.23%
Ins Owner ChangeN/A
Market Cap550.28M
Revenue(TTM)393.96M
Net Income(TTM)58.75M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.29%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP23.67%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-20
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.63
Fwd PE 9.1
P/S 1.4
P/FCF 5.22
P/OCF 4.77
P/B 0.44
P/tB 0.44
EV/EBITDA 6.93
EPS(TTM)1.9
EY10.38%
EPS(NY)2.01
Fwd EY10.98%
FCF(TTM)3.51
FCFY19.16%
OCF(TTM)3.84
OCFY20.98%
SpS13.1
BVpS41.43
TBVpS41.43
PEG (NY)N/A
PEG (5Y)N/A
Graham Number42.09
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROCE 7.63%
ROIC 5.5%
ROICexc 5.73%
ROICexgc 5.9%
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
FCFM 26.77%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexgc growth 3Y4.23%
ROICexgc growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score9
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Debt/EBITDA 3.87
Cap/Depr 841.25%
Cap/Sales 2.54%
Interest Coverage 250
Cash Conversion 75.16%
Profit Quality 179.48%
Current Ratio 3.44
Quick Ratio 3.44
Altman-Z 1.71
F-Score9
WACC5.6%
ROIC/WACC0.98
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.36%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y265.25%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y122.64%
OCF growth 3Y10.64%
OCF growth 5Y25.86%

MELCOR DEVELOPMENTS LTD / MRD.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MRD.CA.


Can you provide the valuation status for MELCOR DEVELOPMENTS LTD?

ChartMill assigns a valuation rating of 7 / 10 to MELCOR DEVELOPMENTS LTD (MRD.CA). This can be considered as Undervalued.


How profitable is MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

MELCOR DEVELOPMENTS LTD (MRD.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Price/Earnings (PE) ratio for MELCOR DEVELOPMENTS LTD (MRD.CA) is 9.63 and the Price/Book (PB) ratio is 0.44.


Can you provide the dividend sustainability for MRD stock?

The dividend rating of MELCOR DEVELOPMENTS LTD (MRD.CA) is 5 / 10 and the dividend payout ratio is 23.67%.